Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
about
Characterization of cluster of differentiation 47 expression and its potential as a therapeutic target in esophageal squamous cell cancer.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.Standing in the Shifting Sands of Molecular Targeting and Precision Medicine Is the Oasis of 21st-Century Oncology Therapeutics.Construction, Expression, and Characterization of rSEA-EGF and In Vitro Evaluation of its Antitumor Activity Against Nasopharyngeal Cancer.Recent Progress in European Advanced Therapy Medicinal Products and Beyond
P2860
Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
@en
type
label
Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
@en
prefLabel
Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
@en
P2093
P2860
P356
P1476
Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
@en
P2093
Anusha Ande
Deborah A Altomare
Jeff Kamta
Sihem Ait-Oudhia
P2860
P356
10.3389/FONC.2017.00064
P50
P577
2017-04-18T00:00:00Z